Connect with us

Technology

OmniScience’s clinical trial genAI-powered control tower, Vivo, wins 1st place in the CNS Summit 2024 Innovation Showcase

Published

1 year ago

on

OmniScience was awarded top honors at the 2024 Innovation Showcase for its groundbreaking solution, Vivo – a market-first solution poised to transform clinical trial operation teams’ day-to-day workflow and ability to optimize trial insights with genAI

HOUSTON, Nov. 26, 2024 /PRNewswire-PRWeb/ — The CNS Summit (Collaborating for Novel Solutions) was founded in 2010 by life sciences leaders devoted to discovering better, more efficient ways to advance the life sciences industry through innovation, collaboration, and technology.

Patients are waiting: The CNS Summit brings together life sciences leaders who aren’t afraid to challenge the status quo when it comes to the development of new treatments for patients

At the November 2024 CNS Summit in Boston, OmniScience was awarded top honors at the Innovation Showcase for its groundbreaking solution, Vivo – a market-first solution poised to transform clinical trial operation teams’ day-to-day workflow and ability to optimize trial insights with genAI.

CNS Summit Chairman and Chief Curator, Dr. Amir Kalali, stated, “At CNS Summit, we are proud to support leading startups. The CNS Summit Innovation Showcase is a competitive process with independent judging that showcases the top new startups in the life science ecosystem.”

“This award is a testament to the transformative impact of Vivo and the dedication of our team at OmniScience,” said Angela Holmes, CEO of OmniScience. “Winning the Innovation Showcase validates our vision of unifying clinical trial data to empower teams with real-time insights that drive faster, smarter decisions. We are honored to be recognized by our peers and remain committed to advancing clinical development for better patient outcomes in neurology and psychiatry and beyond.”

The CNS Summit Innovation Showcase is a stage for forward-thinking companies to share solutions that address pressing challenges in clinical development. This year’s submissions underwent a rigorous peer-review process, with Vivo being selected as one of the top four finalists based on its innovation, novelty, and potential impact on clinical research. Judges of the summit ultimately awarded Vivo the top position, recognizing its ability to streamline data accessibility and support actionable insights that reduce clinical trial timelines and increase probability of success. Notable organizations in attendance at the 2024 Summit included AbbVie, AstraZeneca, Bayer, Bristol Myers Squibb, GSK, Johnson & Johnson, Novo Nordisk, Pfizer, Roche, and Takeda.

Driving Efficiency in Complex Trials and Addressing the Challenges of Siloed Data in Clinical Trials:

“Clinical trial complexity is skyrocketing, especially in CNS trials, where we’re dealing with diverse data types from labs, sensors, digital biomarkers, and imaging,” said Michael Bell, PhD, VP of Product at OmniScience, who led the showcase presentation. “Vivo changes the game for biopharma teams, enabling them to access on-demand insights, detect data discrepancies, forecast enrollment timelines, and monitor site, safety, and clinical metrics—all in one unified portal. Our team at OmniScience has drawn on years of experience in clinical data science to bring Vivo to life, and this win reinforces our commitment to accelerating therapeutic development.”

Vivo was developed to address the significant hurdles clinical operations teams face in managing siloed data, which impede timely, informed decision-making. During his presentation, Dr. Bell demonstrated how Vivo’s genAI capabilities allow teams to ask complex questions—such as identifying operational and safety risks and monitoring data quality and completeness—and receive instant, plain-language answers. Vivo’s AI-driven approach enables the delivery of proactive notifications, helping teams make informed adjustments throughout their trials.

Designed with explainability and interpretability at its core, Vivo ensures that every generated insight is supported by clear, traceable rationale grounded in data and clinical context. Its advanced cognitive architecture combines ontological knowledge of trial protocols with domain-specific clinical expertise, enabling qualitative and quantitative reasoning at scale.

“We are proud to be recognized by our peers for Vivo’s potential to transform how biopharma approaches clinical trial data,” Bell shared. “OmniScience has built a product that empowers study teams and their CROs with the oversight and insights they need to get critical treatments to patients faster.”

About the CNS Summit Innovation Showcase:

The CNS Summit Innovation Showcase is an annual opportunity for emerging companies to spotlight their innovative solutions in clinical research. This event brings together technology companies and industry leaders, creating a collaborative environment where groundbreaking ideas meet strategic partners. Through peer review, attendee voting, and independent judging, the showcase rewards innovation that has the potential to accelerate the development of life-changing therapies.

About OmniScience:

OmniScience is a trusted partner to leading life science organizations advancing clinical R&D missions through unparalleled expertise in clinical data science. Our expert team has served biopharma as a data science CRO, developing AI/ML solutions to translate complex clinical trial data into insights.

We believe in a future where all clinical trial data can be unified and translated into knowledge in real time. That’s why we created Vivo – your new favorite clinical development colleague.

Improve monitoring and oversight. Make better decisions with higher quality data. Reduce cost. Shorten timelines. If you would like to discuss how we can support your clinical trials, reach us at hello@omniscience.bio or on LinkedIn.

Media Contact
Carla Holloway, OmniScience, 1 3023790441, carla.holloway@omniscience.bio, omniscience.bio

View original content to download multimedia:https://www.prweb.com/releases/omnisciences-clinical-trial-genai-powered-control-tower-vivo-wins-1st-place-in-the-cns-summit-2024-innovation-showcase-302316131.html

SOURCE OmniScience

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

EX3 Accelerates APAC Expansion with Malaysia Growth Milestone and SAP Partnership

Published

21 minutes ago

on

April 21, 2026

By

LONDON and KUALA LUMPUR, Malaysia, April 21, 2026 /PRNewswire/ — EX3 today announced a significant milestone in its Asia-Pacific (APAC) growth journey, marked by continued expansion in Malaysia, a newly formalised SAP partnership, and further investment in regional leadership.

As part of its broader APAC growth strategy, EX3 has strengthened its presence in Malaysia, with headcount increasing to 21 employees—an addition of four new team members in the last six months alone, with additional two expected by end of May 2026. This growth reflects sustained demand for EX3’s expertise in delivering end-to-end HR and payroll transformation programmes across the region.

In parallel, EX3 has been officially inducted as an SAP Partner in Malaysia, with a dedicated focus on Human Capital Management (HCM) and Payroll. This milestone represents a strategic step forward, reinforcing EX3’s capability to deliver enhanced value to clients through deeper alignment with SAP technologies and innovation.

The SAP partnership is central to EX3’s regional ambitions, enabling the organisation to scale its delivery and sales capabilities across Malaysia and the wider APAC market. By combining SAP’s leading cloud solutions with EX3’s agile, AI-powered delivery approach, the company is well-positioned to support organisations navigating complex HR and payroll transformations.

Sam Garwood, Chief Revenue Officer at EX3, commented:
“Our SAP partnership represents a key enabler for our go-to-market strategy across APAC. With Malaysia at the centre of our regional operations, we are building a scalable, high-impact GTM engine that allows us to bring EX3’s full capabilities to market with greater speed and precision. This positions us strongly to capture growing demand for HR and payroll transformation across the region.”

Looking ahead, EX3 will continue to invest in its regional leadership team, including the upcoming appointment of a new Head of Sales for APAC. This role will be instrumental in driving continued growth, strengthening client relationships, and expanding EX3’s footprint across key markets.

Jas Rai, CEO of EX3, added:
“EX3 is on a strong global growth trajectory, and our expansion in APAC is a critical part of that journey. Malaysia plays a pivotal role in enabling that growth—both as a centre of delivery excellence and as a strategic hub for the region. As we continue to scale, our investment in Malaysia will help us accelerate our broader ambitions and deliver even greater value to clients globally.”

About EX3

EX3 is a global provider of end-to-end SAP Payroll and HR transformation, combining strategic advisory with outcome-based support and managed services to streamline global operations for organizations worldwide. With offices in the UK, Malaysia, and India, EX3 delivers modern, scalable, and innovative solutions that help clients transform how they manage HR and payroll operations.

https://www.weareex3.com/ 

Media Contact:
Sach Dhanjal
Senior Marketing Manager, EX3
sach.dhanjal@weareex3.com

Logo – https://mma.prnewswire.com/media/2957617/EX3_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ex3-accelerates-apac-expansion-with-malaysia-growth-milestone-and-sap-partnership-302745004.html

Continue Reading

Technology

EX3 Accelerates APAC Expansion with Malaysia Growth Milestone and SAP Partnership

Published

21 minutes ago

on

April 21, 2026

By

LONDON and KUALA LUMPUR, Malaysia, April 21, 2026 /PRNewswire/ — EX3 today announced a significant milestone in its Asia-Pacific (APAC) growth journey, marked by continued expansion in Malaysia, a newly formalised SAP partnership, and further investment in regional leadership.

As part of its broader APAC growth strategy, EX3 has strengthened its presence in Malaysia, with headcount increasing to 21 employees—an addition of four new team members in the last six months alone, with additional two expected by end of May 2026. This growth reflects sustained demand for EX3’s expertise in delivering end-to-end HR and payroll transformation programmes across the region.

In parallel, EX3 has been officially inducted as an SAP Partner in Malaysia, with a dedicated focus on Human Capital Management (HCM) and Payroll. This milestone represents a strategic step forward, reinforcing EX3’s capability to deliver enhanced value to clients through deeper alignment with SAP technologies and innovation.

The SAP partnership is central to EX3’s regional ambitions, enabling the organisation to scale its delivery and sales capabilities across Malaysia and the wider APAC market. By combining SAP’s leading cloud solutions with EX3’s agile, AI-powered delivery approach, the company is well-positioned to support organisations navigating complex HR and payroll transformations.

Sam Garwood, Chief Revenue Officer at EX3, commented:
“Our SAP partnership represents a key enabler for our go-to-market strategy across APAC. With Malaysia at the centre of our regional operations, we are building a scalable, high-impact GTM engine that allows us to bring EX3’s full capabilities to market with greater speed and precision. This positions us strongly to capture growing demand for HR and payroll transformation across the region.”

Looking ahead, EX3 will continue to invest in its regional leadership team, including the upcoming appointment of a new Head of Sales for APAC. This role will be instrumental in driving continued growth, strengthening client relationships, and expanding EX3’s footprint across key markets.

Jas Rai, CEO of EX3, added:
“EX3 is on a strong global growth trajectory, and our expansion in APAC is a critical part of that journey. Malaysia plays a pivotal role in enabling that growth—both as a centre of delivery excellence and as a strategic hub for the region. As we continue to scale, our investment in Malaysia will help us accelerate our broader ambitions and deliver even greater value to clients globally.”

About EX3

EX3 is a global provider of end-to-end SAP Payroll and HR transformation, combining strategic advisory with outcome-based support and managed services to streamline global operations for organizations worldwide. With offices in the UK, Malaysia, and India, EX3 delivers modern, scalable, and innovative solutions that help clients transform how they manage HR and payroll operations.

https://www.weareex3.com/ 

Media Contact:
Sach Dhanjal
Senior Marketing Manager, EX3
sach.dhanjal@weareex3.com

Logo – https://mma.prnewswire.com/media/2957617/EX3_Logo.jpg

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/ex3-accelerates-apac-expansion-with-malaysia-growth-milestone-and-sap-partnership-302745004.html

Continue Reading

Technology

World Micro Tees Up for Angel Flight Soars on May 13, 2026

Published

21 minutes ago

on

April 21, 2026

By

ROSWELL, Ga., April 21, 2026 /PRNewswire/ — To support the critical need for specialized medical care requiring distant travel, World Micro is proud to announce its participation as an Angelic Hole Sponsor for the 2026 Atlanta Tournament of Angels. This annual charity golf tournament directly benefits Angel Flight Soars, a nonprofit organization based out of Peachtree Dekalb Airport in Chamblee, GA.

Angel Flight Soars provides free air transportation for individuals in need of medical care or other critical services. By coordinating volunteer pilots and donated flight resources, the organization helps remove transportation barriers, ensuring patients can access life-saving treatments, specialized care, and humanitarian support.

To secure a sponsorship or learn more about participation in this impactful event, visit Tournament of Angels

“As an Angelic Hole Sponsor for the 2026 Atlanta Tournament of Angels, World Micro is proud to stand behind Angel Flight Soars, a local nonprofit in our community, and support their mission of providing essential, free air transportation for individuals who must travel far from home for specialized medical care,” said Lauren Brown, Director of Business Development.

Supporting Critical Medical Air Transportation

The 2026 Atlanta Tournament of Angels brings together community members and organizations to contribute to a vital cause. Every shot taken during the tournament helps provide essential air transportation for patients requiring specialized medical care far from their homes. This support ensures that geographical distance does not hinder access to critical treatments.

Event Details and Community Impact

The 2026 Atlanta Tournament of Angels will take place on May 13, 2026, at the Chateau Elan Golf Club. As an Angelic Hole Sponsor, World Micro underscores the profound impact of community support for services like those provided by Angel Flight Soars. The tournament offers a unique opportunity for individuals and organizations to contribute to a cause that provides essential medical air transportation, ensuring patients can access critical care regardless of distance. 

About World Micro

World Micro is a global distributor specializing in electronic components and supply chain solutions for military, aerospace, industrial, and high-reliability applications. With a focus on speed, service, and dependable fulfillment, World Micro supports customers worldwide with responsive sourcing, logistics expertise, and value-added distribution services.

Learn more at www.worldmicro.com.

For pricing and inquiries, please contact World Micro at:
Email: info@worldmicro.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/world-micro-tees-up-for-angel-flight-soars-on-may-13-2026-302748030.html

SOURCE World Micro

Continue Reading

Trending